Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus

Journal of Nuclear Cardiology

Volumn 13, Issue 1, 2006, Pages 34-42

  Nagamachi, Shigeki ^a   Fujita, Seigo ^a   Nishii, Ryuichi ^a   Futami, Shigemi ^a   Tamura, Shozo ^a   Mizuta, Masanari ^a   Nakazato, Masamitsu ^a   Kurose, Takeshi ^a   Wakamatsu, Hideyuki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Cardiac event; Iodine 123 metaiodobenzylguanidine; Mortality rate; Non insulin dependent diabetes mellitus; Prognostic value

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ADENOSINE TRIPHOSPHATE; RADIOISOTOPE; THALLIUM 201;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; FOLLOW UP; HEART RATE VARIABILITY; HEART SCINTISCANNING; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RR INTERVAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNIVARIATE ANALYSIS;

3-IODOBENZYLGUANIDINE; AUTONOMIC NERVOUS SYSTEM DISEASES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HEART DISEASES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 32044475429     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2005.11.009     Document Type: Article

References (53)

1. A.I. Vinik R. Freeman T. Ebras Diabetic autonomic neuropathy Semin Neurol 23 2003 365-372
2. D. Ziegler F.A. Gries H. Muhlen W. Rathmann M. Spuler F. Lessmann The DiaCAN Multicenter Study Group Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes center Diabete Metab 19 1993 143-151
3. A.I. Vinik R.E. Maser B.D. Mitchell R. Freeman Diabetic autonomic neuropathy Diabetes Care 26 2003 1553-1579
4. D. Ziegler Cardiovascular autonomic neuropathy clinical manifestations and measurement Diabetes Rev 7 1999 300-315
5. J.C. Sisson D.M. Wieland P. Sherman T.J. Mangner M.C. Tobes S. Jacques Jr Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function J Nucl Med 28 1987 1620-1624
6. P. Srikanthan W. Hsueh Preventing heart failure in patients with diabetes Med Clin North Am 88 2004 1237-1256
7. R. Freeman P. Saul M. Roberts R.D. Berger C. Broadbridge R. Cohen Spectral analysis of heart rate in diabetic autonomic neuropathy Arch Neurol 48 1991 185-190
8. M. Risk V. Bril C. Broadbridge A. Cohen Heart rate variability measurement in diabetic neuropathy review of methods Diabetes Technol Ther 3 2001 63-76
9. S. Kageyama I. Taniguchi N. Tajima N. Saito Y. Ikeda M. Abe A critical level of diabetic autonomic neuropathy Auton Nerv Syst 20 1983 76-80
10. S.G. Wheeler J.H. Ahroni E.J. Boyko Prospective study of autonomic neuropathy as a predictor of mortality in patients with diabetes Diabetes Res Clin Pract 58 2002 131-138
11. D.M. Wieland L.E. Brown W.L. Rogers K.C. Worthington J.L. Wu N.H. Clinthorne et al. Myocardial imaging with a radioiodinated norepinephrine storage analogue J Nucl Med 22 1981 22-31
12. E.B. Henderson J.K. Kahn J.R. Corbett D.E. Jansen J.J. Pippin P. Kulkarni et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy Circulation 78 1988 1192-1199
13. A. Langer M.R. Freeman R.G. Josseg P.W. Armstrong Metaiodobenzyl-guanidine imaging in diabetes mellitus assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent ischemia J Am Coll Cardiol 25 1995 610-618
14. P. Merlet H. Valette J.L. Dubois-Rande D. Moyse D. Duboc P. Dove et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure J Nucl Med 33 1992 471-477
15. T. Nakata T. Wakabayashi M. Kyuma T. Takahashi A. Hashimoto H. Ogata et al. Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction J Card Fail 9 2003 113-121
16. K. Sakata K. Iida M. Kudo H. Yoshida O. Doi Prognostic value of I-123 metaiodobenzylguanidine imaging in vasospastic angina without significant coronary stenosis Circ J 69 2005 171-176
17. T. Yamada T. Shimonagata M. Fukunami K. Kumagai H. Ogita A. Hirata et al. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure a prospective study J Am Coll Cardiol 41 2003 231-238
18. K. Utsunomiya I. Narabayashi Y. Nakatani K. Tamura S. Onishi I-123 MIBG cardiac imaging in diabetic neuropathy before and after epalrestat therapy Clin Nucl Med 24 1999 418-420
19. K. Utsunomiya I. Narabayashi K. Tamura Y. Nakatani Y. Saika S. Onishi et al. Effects of aldose reductase inhibitor and vitamin B12 on myocardial uptake of iodine-123 metaiodobenzylguanidine in patients with non-insulin-dependent diabetes mellitus Eur J Nucl Med 25 1998 1643-1648
20. 123I-MIBG myocardial scintigraphy in non-insulin dependent diabetes mellitus Ann Nucl Med 16 2002 33-38
21. J.R. Cook J.T. Bigger Jr R.E. Kleiger J.L. Fleiss R.C. Steinman L.M. Rolnitzky Effect of atenolol and diltiazem on heart period variability in normal persons J Am Coll Cardiol 17 1991 480-484
22. A.G. Kontopoulos V.G. Athyros A.A. Papageorgiou V.M. Skeberis E.C. Basayiannis H. Boudoulas Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients Coron Artery Dis 8 1997 517-524
23. S. Nagamachi S. Jinnouchi H. Nakahara L.G. Flores II T. Ohnishi H. Hoshi S. Futami et al. 123I-MIBG myocardial scintigraphy in diabetic patients relationship to autonomic neuropathy Nucl Med Commun 17 1996 621-632
24. 201Tl uptake and cardiac autonomic function Ann Nucl Med 12 1998 323-331
25. N. Takahashi M. Nakagawa T. Saikawa T. Ooie K. Yufu S. Shigematsu et al. Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients J Am Coll Cardiol 38 2001 232-237
26. S. Tatsuya K. Oba Y. Igari M. Matsumura Y. Inuzuka Y. Kigawa et al. Relation of apolipoprotein (a) phenotypes to diabetic retinopathy in elderly type 2 diabetes J Nippon Med Sch 69 2002 31-38
27. P.A. McKee W.P. Castelli P.M. McNamara W.B. Kannel The natural history of congestive heart failure the Framingham study N Engl J Med 285 1971 1441-1446
28. B. Zola J.K. Kahn J.E. Juni A.I. Vinik Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease J Clin Endocrinol Metab 63 1986 208-214
29. M.F. Di Carli D. Bianco-Batlles M.E. Landa A. Kazmers H. Groehn O. Muzik G. Grunberger Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus Circulation 100 1999 813-819
30. E. Standl O. Schnell A new look at the heart in diabetes mellitus from ailing to failing Diabetologia 43 2000 1455-1469
31. J. Shofer R. Spielmann A. Schuchert K. Weber M. Schluter Iodine-123 metaiodobenzylguanidine scintigraphy a noninvasive method to demonstrate myocardial adrenergic nerve system disintegrity in patients with idiopathic dilated cardiomyopathy J Am Coll Cardiol 12 1988 1252-1258
32. Y. Imamura H. Ando W. Mitsuoka S. Egashira H. Masaki T. Ashihara et al. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause J Am Coll Cardiol 26 1995 1594-1599
33. M. Mantysaari J. Kuikka J. Mustonen K. Tahvanainen E. Vanninen E. Lansimies et al. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine Diabetes 41 1992 1069-1075
34. O. Schnell C.M. Kirsch J. Stemplinger M. Haslbeck E. Standl Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy Diabetologia 38 1995 1345-1352
35. K. Tamura K. Utsunomiya Y. Nakatani Y. Saika S. Onishi T. Iwasaka Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus Eur J Nucl Med 26 1999 1310-1316
36. K.H. Lee H.J. Jang Y.H. Kim E.J. Lee Y.S. Choe Y. Choi et al. Prognostic value of cardiac autonomic neuropathy independent and incremental to perfusion defects in patients with diabetes and suspected coronary artery disease Am J Cardiol 92 2003 1458-1461
37. D.J. Ewing I.W. Campel B.F. Clarke Mortality in diabetic autonomic neuropathy Lancet 1 1976 601-603
38. B. Takase A. Kurita M. Noritake A. Uehata T. Maruyama H. Nagayoshi et al. Heart rate variability in patients with diabetes mellitus, ischemic heart disease, and congestive heart failure J Electrocardiol 25 1992 79-88
39. R.E. Kleiger J.P. Miller R.J. Krone J.T. Bigger The independence of cycle length variability and exercise testing on predicting mortality of patients surviving acute myocardial infarction Am J Cardiol 65 1990 408-411
40. E.A. Whitsel E.J. Boyko D.S. Siscovick Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes a meta-analysis Diabetes Care 23 2000 241-247
41. P.T. Sawicki R. Dähne R. Bender M. Berger Prolonged QTc interval as a predictor of mortality in diabetic nephropathy Diabetologia 39 1996 77-81
42. D. Claus O. Meudt C. Rozeik K. Engelmann-Kempe P.E. Huppert H. Wietholtz Prospective investigation of autonomic cardiac neuropathy in diabetes mellitus Clin Auton Res 12 2002 373-378
43. K. Wei P. Dorian D. Newmann A. Langer Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus J Am Coll Cardiol 26 1995 859-863
44. I.A. O'Brien J.P. McFadden R.J.M. Corrall The influence of autonomic neuropathy on mortality in insulin-dependent diabetes Q J Med 290 1991 495-502
45. D. Ziegler Diabetic cardiovascular autonomic neuropathy prognosis, diagnosis and treatment Diabetes Metab Rev 10 1994 339-383
46. H. Miettinen S. Lehto V. Salomaa M. Mahonen M. Niemela S.M. Haffner et al. Impact of diabetes on mortality after the first myocardial infarction the FINMONICA myocardial infarction Register Study Group Diabetes Care 21 1998 69-75
47. W. Rathman D. Ziegler M. Jahnke B. Haastert F.A. Gries Mortality in diabetic patients with cardiovascular autonomic neuropathy Diabet Med 10 1993 820-824
48. T.J. Orchard C.E. Lloyd R.E. Maser L.H. Kuller Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study Diabetes Res Clin Pract 34 Suppl 1996 S165-S171
49. B. Egan G. Gleim J. Panish Use of losartan in diabetic patients in the primary care setting review of the results in LIFE and RENAAL Curr Med Res Opin 20 2004 1909-1917
50. M. Kaminek M. Myslivecek M. Skvarilova O. Weinbergova R. Metelka V. Husak et al. Prognostic significance of stress tomographic scintigraphy of myocardial perfusion in diabetic patients [in Czech] Vnitr Lek 47 2001 739-743
51. M.P. Garancini C. Gobbi A. Errera A. Sergi G. Gallus Age-specific prevalence and duration of known diabetes. The Cremona study Diabetes Care 19 1996 1279-1282
52. L.A. Scott P.L. Kench Cardiac autonomic neuropathy in the diabetic patient does 123I-MIBG imaging have a role to play in early diagnosis? J Nucl Med Technol 32 2004 66-71
53. I. Carrio Cardiac neurotransmission imaging J Nucl Med 42 2001 1062-1076